Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention

OBJECTIVES: To evaluate the safety and tolerability of palivizumab for RSV prophylaxis in high-risk children in everyday practice. METHODS: High-risk children prophylaxed against RSV infection were recruited into a prospective, observational, Canadian RSV Evaluation Study of Palivizumab (CARESS) reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinghan Jenny, Chan, Parco, Paes, Bosco, Mitchell, Ian, Li, Abby, Lanctôt, Krista L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523213/
https://www.ncbi.nlm.nih.gov/pubmed/26237402
http://dx.doi.org/10.1371/journal.pone.0134711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523213/
https://www.ncbi.nlm.nih.gov/pubmed/26237402
http://dx.doi.org/10.1371/journal.pone.0134711

Ejemplares similares